X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3864) 3864
Book Review (733) 733
Publication (291) 291
Book Chapter (23) 23
Conference Proceeding (5) 5
Magazine Article (2) 2
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3281) 3281
humans (2989) 2989
ophthalmology (2704) 2704
intravitreal injections (1921) 1921
male (1906) 1906
female (1847) 1847
aged (1412) 1412
bevacizumab (1325) 1325
middle aged (1321) 1321
ranibizumab (1156) 1156
vascular endothelial growth factor a - antagonists & inhibitors (1081) 1081
macular degeneration (1055) 1055
treatment outcome (933) 933
tomography, optical coherence (835) 835
aged, 80 and over (805) 805
angiogenesis inhibitors - administration & dosage (800) 800
angiogenesis inhibitors - therapeutic use (771) 771
retrospective studies (740) 740
endothelial growth-factor (728) 728
vascular endothelial growth factor (724) 724
visual acuity (681) 681
macular edema - drug therapy (665) 665
eye diseases (653) 653
follow-up studies (625) 625
fluorescein angiography (614) 614
visual acuity - physiology (603) 603
intravitreal injection (601) 601
adult (589) 589
angiogenesis inhibitors - adverse effects (553) 553
animals (538) 538
diabetic retinopathy (530) 530
injection (521) 521
prospective studies (501) 501
retina (477) 477
genetic structures (471) 471
care and treatment (465) 465
intravitreal bevacizumab (440) 440
edema (386) 386
injections (380) 380
macular edema (376) 376
medicine & public health (376) 376
diabetic retinopathy - drug therapy (372) 372
antibodies, monoclonal, humanized (371) 371
macular degeneration - drug therapy (370) 370
triamcinolone (364) 364
therapy (363) 363
antibodies, monoclonal, humanized - administration & dosage (362) 362
pharmacology & pharmacy (362) 362
choroidal neovascularization - drug therapy (361) 361
photodynamic therapy (354) 354
glucocorticoids - administration & dosage (353) 353
sense organs (348) 348
antibodies, monoclonal, humanized - therapeutic use (334) 334
choroidal neovascularization (334) 334
macular edema - etiology (322) 322
surgery (322) 322
diabetes (320) 320
diabetic macular edema (318) 318
neovascularization (309) 309
optical coherence tomography (306) 306
age-related macular degeneration (305) 305
risk factors (305) 305
wet macular degeneration - drug therapy (305) 305
analysis (303) 303
vitreous body (303) 303
eye (293) 293
drug therapy (288) 288
retinopathy (288) 288
safety (286) 286
vitrectomy (286) 286
avastin (280) 280
antibodies, monoclonal, humanized - adverse effects (273) 273
time factors (270) 270
triamcinolone acetonide (266) 266
research (263) 263
visual acuity - drug effects (254) 254
endophthalmitis (253) 253
glucocorticoids - adverse effects (252) 252
physiological aspects (249) 249
degeneration (246) 246
patients (246) 246
abridged index medicus (241) 241
retina - pathology (237) 237
efficacy (234) 234
vegf (228) 228
studies (223) 223
dexamethasone (222) 222
retinal vein occlusion (222) 222
clinical trials (220) 220
intraocular pressure (220) 220
verteporfin (219) 219
glaucoma (216) 216
intraocular pressure - drug effects (215) 215
antibodies, monoclonal - administration & dosage (214) 214
intravitreal injections - adverse effects (214) 214
age (212) 212
macular edema - physiopathology (211) 211
corticosteroids (209) 209
intravitreal triamcinolone (209) 209
retinal vein occlusion - drug therapy (209) 209
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3729) 3729
German (55) 55
French (32) 32
Spanish (13) 13
Japanese (10) 10
Korean (10) 10
Polish (4) 4
Russian (4) 4
Turkish (4) 4
Chinese (3) 3
Portuguese (3) 3
Czech (2) 2
Danish (1) 1
Italian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAMA, ISSN 0098-7484, 11/2015, Volume 314, Issue 20, pp. 2137 - 2146
Journal Article
BMJ : British Medical Journal, ISSN 0959-8138, 7/2012, Volume 345, Issue 7866, pp. 16 - 16
Objective To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs.Design... 
Myocardial infarction | RESEARCH | Vascular endothelial growth factors | Intravenous injections | Intravitreal injections | Health care industry | Strokes | Venous thrombosis | Congestive heart failure | Research universities | Universities | MORTALITY | RISKS | MEDICINE, GENERAL & INTERNAL | THERAPY | PHARMACOKINETICS | BEVACIZUMAB | SAFETY | MACULAR DEGENERATION | RANIBIZUMAB | CANCER | COHORT ANALYSIS | Myocardial Infarction - chemically induced | Myocardial Infarction - epidemiology | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Case-Control Studies | Bevacizumab | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Stroke - chemically induced | Ranibizumab | Female | Stroke - epidemiology | Brain Ischemia - chemically induced | Venous Thromboembolism - epidemiology | Angiogenesis Inhibitors - adverse effects | Brain Ischemia - epidemiology | Antibodies, Monoclonal, Humanized - adverse effects | Intravitreal Injections - adverse effects | Risk Factors | Logistic Models | Ontario - epidemiology | Venous Thromboembolism - chemically induced | Aged | Retinal Diseases - drug therapy | Heart Failure - chemically induced | Drugs | Cardiovascular disease | Risk | Side effects | Vascular endothelial growth factor | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2015, Volume 160, Issue 1, pp. 17 - 25.e1
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2015, Volume 160, Issue 4, pp. 842 - 843
  Topical antiseptic use in 2 centers (8%) was not related with incidence of endophthalmitis in univariate analysis (P = .534); the multivariate analysis was... 
Ophthalmology | OPHTHALMOLOGY | Intravitreal Injections - adverse effects | Humans | Female | Male | Eye Infections, Bacterial - epidemiology | Endophthalmitis - epidemiology | Visual Acuity - physiology | Confidence intervals | Antibiotics | Multivariate analysis | Index Medicus | Abridged Index Medicus
Journal Article
Retina, ISSN 0275-004X, 01/2017, Volume 37, Issue 12, pp. 2341 - 2346
Purpose: To evaluate the rate of presumed endophthalmitis (EO) after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections in three... 
Endophthalmitis | Anti-VEGF | Safety | Laminar airflow | Intravitreal injections | Operating room | SURGERY | VEGF | anti-VEGF | PREVENTION | MACULAR DEGENERATION | CONTAMINATION | ANTIBIOTIC-PROPHYLAXIS | TRIAL | safety | OPHTHALMOLOGY | AFLIBERCEPT | intravitreal injections | endophthalmitis | POVIDONE-IODINE | RANIBIZUMAB | laminar airflow | operating room | Follow-Up Studies | Humans | Aptamers, Nucleotide - administration & dosage | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Endophthalmitis - epidemiology | Endophthalmitis - etiology | Incidence | Eye Infections, Bacterial - etiology | Angiogenesis Inhibitors - administration & dosage | Time Factors | Operating Rooms | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Recombinant Fusion Proteins - administration & dosage | Equipment Contamination - statistics & numerical data | Intravitreal Injections - adverse effects | Bevacizumab - administration & dosage | Risk Factors | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - diagnosis | Intravitreal Injections - instrumentation | Wet Macular Degeneration - drug therapy | Switzerland - epidemiology | Denmark - epidemiology | Ranibizumab - administration & dosage | Eye Infections, Bacterial - epidemiology | Wet Macular Degeneration - surgery | Index Medicus
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2015, Volume 160, Issue 4, pp. 843 - 844
  According to the article by Falavarjani and associates,3 the risk of endophthalmitis after resident intravitreal injection is low and similar to when... 
Ophthalmology | OPHTHALMOLOGY | Intravitreal Injections - adverse effects | Humans | Female | Male | Eye Infections, Bacterial - epidemiology | Endophthalmitis - epidemiology | Visual Acuity - physiology | Vascular endothelial growth factor | Lung cancer | Index Medicus | Abridged Index Medicus
Journal Article
Retina, ISSN 0275-004X, 02/2015, Volume 35, Issue 7, pp. 1401 - 1406
Journal Article